Merck & Co(MRK) Stock Price Today | Quotes & News - Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist

88.110
+0.240+0.27%

Close Mar 26 16:00 ET

88.150
+0.040+0.05%

Post 20:01 ET

222.57BMarket Cap13.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy?
Yahoo Finance18:09 ET
Jim Cramer on Merck (MRK): "I Like It at This Level – But I Like Bristol-Myers Even More!"
Yahoo Finance13:45 ET
Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE Amid Recent 7% Share Price Dip
Yahoo Finance13:32 ET
Chevron, McDonald's Share Gains Contribute To Dow's 118-Point Jump
MarketWatchMar 26 11:18 ET
Merck Receives European Approval for Streptococcal Pneumonia Vaccine
MT NewswiresMar 26 09:44 ET
Summit Therapeutics Rises as Lead Asset Makes Citi Its Latest Bull
Seeking AlphaMar 26 09:23 ET

Comments

Merck to buy Henguri Pharma’s drug for up to $1.8B

$Merck & Co (MRK.US)$

Merck to buy Henguri Pharma’s drug for up to $1.8B

2

$Merck & Co (MRK.US)$ what happen

$Merck & Co (MRK.US)$ reversal

1

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

$Merck & Co (MRK.US)$
Breakthrough: Merck's Novel HIV Two-Drug Combo Achieves 95% Viral Suppression in Phase 3

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

3

$Merck & Co (MRK.US)$

1

Read more